Products and Technologies, Market Outlook

AI in Chemicals Manager’s Playbook for Getting Value from AIin the Chemicals Sector

February 1, 2023

AI in Chemicals Manager’s
Technologies like artificial intelligence (AI) and machine learning (ML) are transforming the way industries think about and consume data to drive operational efficiencies and enhance business performance.

Spotlight

Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals, Inc. is a science-driven, patient-focused company leveraging its strengths across the continuum from drug discovery to commercialization to provide better treatments for people with serious diseases. Achillion’s rational, iterative approach to discovery and development has created a powerful engine for advancing novel small-molecule drugs. Achillion pairs this rigorous science with insights about patients, caregivers, and the healthcare market to choose product candidates with disruptive potential – or the potential to change treatment paradigms. This has already enabled Achillion to generate three clinical-stage oral chronic hepatitis C (HCV) candidates and a proprietary library of over 1,300 potent and specific complement inhibitors. The company’s commitments to scientific excellence and market impact are reinforced by a culture that encourages cross-functional collaboration, organizational nimbleness and resilience, professional courage, and informed risk-

OTHER WHITEPAPERS
news image

Analysis of Hand Sanitizers to Support Label Claims

whitePaper | April 30, 2021

At the height of the first wave of the COVID-19 pandemic, consumers around the world experienced a supply shortage related to alcohol-based hand sanitizer. As new producers entered the market, and existing manufacturers sought to ramp-up production to meet the growing demand, lower grades of ethanol and isopropanol (IPA) started to appear on the market. To ensure the safety and efficacy of hand sanitizer products, it is recommended that manufacturers test their products to ensure appropriate levels of active ingredients, as well as a means of ensuring label-claim accuracy. In this application note, an efficient and simple, “dilute and shoot” method for the analysis of IPA and ethanol in hand sanitizer products is detailed. With a run-time of only 5.36 minutes per sample, this method is ideal for operations requiring fast turnaround times that won’t disrupt the production of their products.

Read More
news image

Minimizing Fire Risk in Thermal Oil Heat Transfer Systems

whitePaper | January 28, 2023

Thermal fluids have proven exceptionally safe in a wide range of industries. However, it is difficult to completely prevent fires in these systems because the necessary ingredients for a fire—fuel, air and ignition source—are present by design.

Read More
news image

White Paper on the Low-carbon Development of the Petrochemical Industry

whitePaper | April 22, 2022

As the impacts of climate change increase, China announced the goal of "striving to peak CO2 emissions by 2030 and achieve carbon neutrality by 2060".

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

Energy transition and decarbonization Pathways for the chemical industry

whitePaper | August 16, 2022

Like all industries, the chemical sector is under pressure to bring its operations and value chain on track toward a more sustainable and resilient energy future. In the medium and long term.

Read More
news image

Decarbonizing the Canadian Chemical and Fertilizer Industry

whitePaper | March 11, 2023

Canada’s economy and the lives of Canadians are highly reliant on the materials and products produced by the chemical and fertilizer industry.

Read More

Spotlight

Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals, Inc. is a science-driven, patient-focused company leveraging its strengths across the continuum from drug discovery to commercialization to provide better treatments for people with serious diseases. Achillion’s rational, iterative approach to discovery and development has created a powerful engine for advancing novel small-molecule drugs. Achillion pairs this rigorous science with insights about patients, caregivers, and the healthcare market to choose product candidates with disruptive potential – or the potential to change treatment paradigms. This has already enabled Achillion to generate three clinical-stage oral chronic hepatitis C (HCV) candidates and a proprietary library of over 1,300 potent and specific complement inhibitors. The company’s commitments to scientific excellence and market impact are reinforced by a culture that encourages cross-functional collaboration, organizational nimbleness and resilience, professional courage, and informed risk-

Events